Bivalent Pfizer Booster Authorized for Infants and Young Children
The FDA expanded emergency use of the bivalent Pfizer booster as a single booster dose for children age 6-months through 4 years-old.
The FDA expanded emergency use of the bivalent Pfizer booster as a single booster dose for children age 6-months through 4 years-old.
A person in the United States has tested positive for highly pathogenic avian influenza A(H5N1) virus—or bird flu.
Bacteria in the mouth may play a role in survival from idiopathic pulmonary fibrosis (IPF), finds a new study.
Five PFF Scholars will receive a $100,000 research grant to improve the understanding of pulmonary fibrosis and treatments.
Morphine delivered in a low, controlled dose reduced chronic cough in idiopathic pulmonary fibrosis patients (IPF).
Legislation designed to ease access to supplemental oxygen for Medicare beneficiaries was introduced in the US House.
A hypoxia trial yields new blood oxygen saturation data that show the accuracy of the Evie Ring exceeds the FDA guidelines.
Harvard researchers have identified a previously unknown way in which the body counteracts restricted breathing.
Video laryngoscopy decreased the number of attempts needed to achieve endotracheal intubation compared with direct laryngoscopy.
More than 450 CoARC-accredited respiratory care educational programs will each receive $10,000 to use toward scholarships for RTs.
High-dose inhaled nitric oxide improved oxygenation and reduced risk of ARDS-related mortality in critically ill Black patients with COVID-19.